Live Breaking News & Updates on Study Treatment

Stay updated with breaking news from Study treatment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Theralase Technologies Inc.: Theralase Release's 2Q2023 Interim Financial Statements

Theralase Technologies Inc.: Theralase Release's 2Q2023 Interim Financial Statements
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Roger Dumoulin White , Kristina Hachey , Kaouthar Lbiati , Arkady Mandel , Company Drug Division Anti , Development Expenses , Toronto Stock Venture Exchange , Company Board Of Directors , Toronto Stock Exchange Venture , Theralase Technologies Inc View , Regulation Services Provider , Venture Exchange , Drug Division , Clean Technology , Theralase Technologies Inc , Company Photo Dynamic Compounds , Ontario Securities Commission , Device Division , Technologies Inc , Life Sciences , Company Annual Meeting On , Photo Dynamic Compounds , Financial Statements , Consolidated Statements , Canadian Dollars ,

Theralase Release's 2Q2023 Interim Financial Statements

Theralase Release's 2Q2023 Interim Financial Statements
torontotelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontotelegraph.com Daily Mail and Mail on Sunday newspapers.

United States , Kaouthar Lbiati , Kristina Hachey , Roger Dumoulin White , Arkady Mandel , Venture Exchange , Company Drug Division Anti , Company Board Of Directors , Toronto Stock Venture Exchange , Company Photo Dynamic Compounds , Theralase Technologies Inc , Drug Division , Toronto Stock Exchange Venture , Regulation Services Provider , Company Annual Meeting On , Technologies Inc , Life Sciences , Clean Technology , Ontario Securities Commission , Photo Dynamic Compounds , Financial Statements , Financial Statements , Drug Division Anti Cancer Therapy , Chief Executive Officer , Chief Scientific Officer , Settlement Agreement ,

Theralase Release's 2Q2023 Interim Financial Statements

Theralase Release's 2Q2023 Interim Financial Statements
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United States , Kaouthar Lbiati , Arkady Mandel , Kristina Hachey , Roger Dumoulin White , Life Sciences , Company Annual Meeting On , Technologies Inc , Ontario Securities Commission , Company Photo Dynamic Compounds , Clean Technology , Theralase Technologies Inc , Regulation Services Provider , Venture Exchange , Drug Division , Toronto Stock Exchange Venture , Company Board Of Directors , Toronto Stock Venture Exchange , Company Drug Division Anti , Photo Dynamic Compounds , Financial Statements , Financial Statements , Drug Division Anti Cancer Therapy , Chief Executive Officer , Chief Scientific Officer , Settlement Agreement ,

Theralase Technologies Inc.: Theralase Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements

In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase® ....

United States , San Francisco , Roger Dumoulin White , Arkady Mandel , Regulation Services Provider , Venture Exchange , American Urology Association , Clean Technology , Life Sciences , Company Annual Meeting On , Company Photo Dynamic Compounds , Ontario Securities Commission , International Bladder Cancer Group , Development Expenses , Toronto Stock Venture Exchange , Technologies Inc , Company Board Of Directors , Theralase Technologies Inc , Theralase Technologies Inc View , Toronto Stock Exchange Venture , American Society Of Clinical Oncology , Company Anti , Tertiary Objectives , Photo Dynamic Compounds , Financial Statements , Consolidated Statements ,

Theralase Technologies Inc.: Theralase Releases 1Q2023 Interim Financial Statements

TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development ....

United States , San Francisco , Roger Dumoulin White , Arkady Mandel , Clean Technology , American Urology Association , Company Photo Dynamic Compounds , Theralase Technologies Inc , Company Anti , Venture Exchange , Regulation Services Provider , Technologies Inc , Company Board Of Directors , Theralase Technologies Inc View , International Bladder Cancer Group , American Society Of Clinical Oncology , Ontario Securities Commission , Development Expenses , Life Sciences , Toronto Stock Exchange Venture , Toronto Stock Venture Exchange , Company Annual Meeting On , Photo Dynamic Compounds , Financial Statements , Consolidated Statements , Canadian Dollars ,